Related Experiment Video
Updated: Mar 29, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Clinical Validation of Type 1 Diabetes Coding in Hospital Discharge Records Using ADA Criteria: Implications for
Rafael Gómez-Coronado-Martín1,2,3, Miguel Ángel Salinero-Fort4,5, Ana López-de-Andrés2
1Servicio de Admisión y Documentación Clínica, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria del Hospital Clínico San Carlos (IdISSC), 28040 Madrid, Spain.
None:
Background/Objectives: Administrative and clinical databases are increasingly used for research, but their value depends on coding accuracy. The Spanish National Hospital Discharge Database (CMBD) is a standardised registry widely applied in epidemiology. Type 1 diabetes mellitus (T1DM) is an autoimmune disease with early onset and long-term complications. This study aimed to validate the accuracy of T1DM diagnoses recorded in the CMBD. Methods: A cross-sectional validation study was conducted at Hospital Clínico San Carlos (Madrid, Spain) including discharges from 2016-2023. Two age- and sex-matched samples of 384 admissions each (with and without T1DM coding, ICD-10 E10) were randomly selected. The gold standard was the confirmation of T1DM based on the diagnostic criteria established by the 2016 American Diabetes Association (ADA) consensus, which remained valid through 2025, verified by a detailed review of electronic health records (EHRs). Sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated with 95% confidence intervals (CIs), and interobserver concordance was assessed with Cohen's kappa. Results: Of the 245,206 discharges, 1324 (0.54%) included a T1DM diagnosis. Validation showed a sensitivity of 100% (95% CI: 98.7-100), specificity of 80.2% (95% CI: 76.4-83.5), PPV of 75.3% (95% CI: 70.7-79.3), and NPV of 100% (95% CI: 99.0-100). Interobserver agreement was excellent (κ = 0.869). Specificity declined with age, from 100% in patients < 30 years to 60% in those ≥ 80 years, mainly due to misclassification with insulin-treated type 2 diabetes. Conclusions: T1DM diagnoses in the CMBD show very high validity and reliability in younger patients, supporting their use in epidemiological and clinical research, while complementary verification is advisable in older adults.
More Related Videos
06:55Inverse Probability of Treatment Weighting Propensity Score using the Military Health System Data Repository and National Death Index
Published on: January 8, 2020
06:50A High-Throughput Electrochemiluminescence 7-Plex Assay Simultaneously Screening for Type 1 Diabetes and Multiple Autoimmune Diseases
Published on: May 29, 2020
Related Concept Videos
Diabetes: Symptoms, Diagnosis, and Complications
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Data Validation
Nursing assessment guides are generally based on holistic models rather than medical...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...